SCHEMBL4934580

SCHEMBL4934580

CCOC(=O)c1nn(-c2cc(F)c(F)cc2F)c2c1C1CCC2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51
NPSR1 Q6W5P4 3/20 0.40
ALDH1A1 P00352 7/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
JMJD6 Q6NYC1 1/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DHODH Q02127 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRA3 P34903 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1432489 0.89 CNR2 (0.66) CNR1CNR2NPSR1MAPTGABRG2
SCHEMBL4932883 0.87 CNR1 (0.54) CNR1CNR2NPSR1ALDH1A1MEN1
SCHEMBL4931788 0.86 CNR1 (0.49) CNR1CNR2NPSR1ALDH1A1MEN1
SCHEMBL4925578 0.83 CNR1 (0.45) CNR1CNR2NPSR1ALDH1A1MEN1
SCHEMBL4925586 0.83 CNR2 (0.54) CNR1CNR2
SCHEMBL4931540 0.83 CNR1 (0.54) CNR1CNR2ALDH1A1MEN1KMT2A
SCHEMBL1431504 0.82 CNR1 (0.53) CNR1CNR2NPSR1ALDH1A1MEN1
SCHEMBL1432222 0.82 CNR2 (0.57) CNR1CNR2NPSR1MAPTGABRG2
SCHEMBL1431633 0.81 ALDH1A1 (0.49) CNR1CNR2NPSR1ALDH1A1MEN1
SCHEMBL1432762 0.80 KDM4E (0.53) CNR1CNR2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200501-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (CH) 2008-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200501-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION CNR2, CNR1, OPRL1 CNR1 2/4885CNR2 1/4885NPSR1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.